These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 32540995)

  • 1. Accessibility of O Antigens Shared between
    Ahmed A; Akhade AS; Qadri A
    J Immunol; 2020 Jul; 205(2):438-446. PubMed ID: 32540995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Refined live attenuated Salmonella enterica serovar Typhimurium and Enteritidis vaccines mediate homologous and heterologous serogroup protection in mice.
    Tennant SM; Schmidlein P; Simon R; Pasetti MF; Galen JE; Levine MM
    Infect Immun; 2015 Dec; 83(12):4504-12. PubMed ID: 26351285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two Novel
    Zhao X; Dai Q; Jia R; Zhu D; Liu M; Wang M; Chen S; Sun K; Yang Q; Wu Y; Cheng A
    Front Cell Infect Microbiol; 2017; 7():391. PubMed ID: 28929089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection against oral challenge three months after i.v. immunization of BALB/c mice with live Aro Salmonella typhimurium and Salmonella enteritidis vaccines is serotype (species)-dependent and only partially determined by the main LPS O antigen.
    Hormaeche CE; Mastroeni P; Harrison JA; Demarco de Hormaeche R; Svenson S; Stocker BA
    Vaccine; 1996 Mar; 14(4):251-9. PubMed ID: 8744548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulated delayed synthesis of lipopolysaccharide and enterobacterial common antigen of Salmonella Typhimurium enhances immunogenicity and cross-protective efficacy against heterologous Salmonella challenge.
    Huang C; Liu Q; Luo Y; Li P; Liu Q; Kong Q
    Vaccine; 2016 Aug; 34(36):4285-92. PubMed ID: 27423383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design of glycoconjugate vaccines against invasive African Salmonella enterica serovar Typhimurium.
    Rondini S; Micoli F; Lanzilao L; Gavini M; Alfini R; Brandt C; Clare S; Mastroeni P; Saul A; MacLennan CA
    Infect Immun; 2015 Mar; 83(3):996-1007. PubMed ID: 25547792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversible synthesis of colanic acid and O-antigen polysaccharides in Salmonella Typhimurium enhances induction of cross-immune responses and provides protection against heterologous Salmonella challenge.
    Li P; Liu Q; Huang C; Zhao X; Roland KL; Kong Q
    Vaccine; 2017 May; 35(21):2862-2869. PubMed ID: 28412074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple immunodominant O-epitopes co-expression in live attenuated Salmonella serovars induce cross-protective immune responses against S. Paratyphi A, S. Typhimurium and S. Enteritidis.
    Li P; Zhang K; Lei T; Zhou Z; Luo H
    PLoS Negl Trop Dis; 2022 Oct; 16(10):e0010866. PubMed ID: 36228043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mucosally delivered Salmonella live vector vaccines elicit potent immune responses against a foreign antigen in neonatal mice born to naive and immune mothers.
    Capozzo AV; Cuberos L; Levine MM; Pasetti MF
    Infect Immun; 2004 Aug; 72(8):4637-46. PubMed ID: 15271924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An enterobacterial common antigen mutant of Salmonella enterica serovar Typhimurium as a vaccine candidate.
    Bridge DR; Whitmire JM; Gilbreath JJ; Metcalf ES; Merrell DS
    Int J Med Microbiol; 2015 Sep; 305(6):511-22. PubMed ID: 26070977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. O-antigen-deficient, live, attenuated Salmonella typhimurium confers efficient uptake, reduced cytotoxicity, and rapid clearance in chicken macrophages and lymphoid organs and induces significantly high protective immune responses that protect chickens against Salmonella infection.
    Senevirathne A; Hewawaduge C; Park S; Park JY; Kirthika P; Lee JH
    Dev Comp Immunol; 2020 Oct; 111():103745. PubMed ID: 32470560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salmonella enterica serovar enteritidis core O polysaccharide conjugated to H:g,m flagellin as a candidate vaccine for protection against invasive infection with S. enteritidis.
    Simon R; Tennant SM; Wang JY; Schmidlein PJ; Lees A; Ernst RK; Pasetti MF; Galen JE; Levine MM
    Infect Immun; 2011 Oct; 79(10):4240-9. PubMed ID: 21807909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SPI1 defective mutants of Salmonella enterica induce cross-protective immunity in chickens against challenge with serovars Typhimurium and Enteritidis.
    Matulova M; Havlickova H; Sisak F; Babak V; Rychlik I
    Vaccine; 2013 Jun; 31(31):3156-62. PubMed ID: 23684831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential Killing of Salmonella enterica Serovar Typhi by Antibodies Targeting Vi and Lipopolysaccharide O:9 Antigen.
    Hart PJ; O'Shaughnessy CM; Siggins MK; Bobat S; Kingsley RA; Goulding DA; Crump JA; Reyburn H; Micoli F; Dougan G; Cunningham AF; MacLennan CA
    PLoS One; 2016; 11(1):e0145945. PubMed ID: 26741681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strain Selection for Generation of O-Antigen-Based Glycoconjugate Vaccines against Invasive Nontyphoidal Salmonella Disease.
    Lanzilao L; Stefanetti G; Saul A; MacLennan CA; Micoli F; Rondini S
    PLoS One; 2015; 10(10):e0139847. PubMed ID: 26445460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of O-antigen delivered by Generalized Modules for Membrane Antigens (GMMA) vaccine candidates against nontyphoidal Salmonella.
    De Benedetto G; Alfini R; Cescutti P; Caboni M; Lanzilao L; Necchi F; Saul A; MacLennan CA; Rondini S; Micoli F
    Vaccine; 2017 Jan; 35(3):419-426. PubMed ID: 27998639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-reactive immune response elicited by parenteral Vi polysaccharide typhoid vaccine against non-typhoid Salmonellae.
    Pakkanen SH; Kantele JM; Herzog C; Kantele A
    Vaccine; 2014 Jan; 32(5):544-51. PubMed ID: 24342246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-reactive cellular and humoral immune responses to Salmonella enterica serovars Typhimurium and Enteritidis are associated with protection to heterologous re-challenge.
    Beal RK; Wigley P; Powers C; Barrow PA; Smith AL
    Vet Immunol Immunopathol; 2006 Nov; 114(1-2):84-93. PubMed ID: 16935350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between antibody susceptibility and lipopolysaccharide O-antigen characteristics of invasive and gastrointestinal nontyphoidal Salmonellae isolates from Kenya.
    Onsare RS; Micoli F; Lanzilao L; Alfini R; Okoro CK; Muigai AW; Revathi G; Saul A; Kariuki S; MacLennan CA; Rondini S
    PLoS Negl Trop Dis; 2015 Mar; 9(3):e0003573. PubMed ID: 25739091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Highly Effective Component Vaccine against Nontyphoidal Salmonella enterica Infections.
    Ferreira RB; Valdez Y; Coombes BK; Sad S; Gouw JW; Brown EM; Li Y; Grassl GA; Antunes LC; Gill N; Truong M; Scholz R; Reynolds LA; Krishnan L; Zafer AA; Sal-Man N; Lowden MJ; Auweter SD; Foster LJ; Finlay BB
    mBio; 2015 Sep; 6(5):e01421-15. PubMed ID: 26396246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.